These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 23585680)

  • 1. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid.
    Conlon J; Burdette DL; Sharma S; Bhat N; Thompson M; Jiang Z; Rathinam VA; Monks B; Jin T; Xiao TS; Vogel SN; Vance RE; Fitzgerald KA
    J Immunol; 2013 May; 190(10):5216-25. PubMed ID: 23585680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential.
    Prantner D; Perkins DJ; Lai W; Williams MS; Sharma S; Fitzgerald KA; Vogel SN
    J Biol Chem; 2012 Nov; 287(47):39776-88. PubMed ID: 23027866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA): Suppresses macrophage capping protein beyond STING activation.
    Xiao Z; Cui X; Liu F; Wang Y; Liu X; Zhou W; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167149. PubMed ID: 38565383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of α-Mangostin as an Agonist of Human STING.
    Zhang Y; Sun Z; Pei J; Luo Q; Zeng X; Li Q; Yang Z; Quan J
    ChemMedChem; 2018 Oct; 13(19):2057-2064. PubMed ID: 30079976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.
    Roberts ZJ; Goutagny N; Perera PY; Kato H; Kumar H; Kawai T; Akira S; Savan R; van Echo D; Fitzgerald KA; Young HA; Ching LM; Vogel SN
    J Exp Med; 2007 Jul; 204(7):1559-69. PubMed ID: 17562815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation.
    Temizoz B; Shibahara T; Hioki K; Hayashi T; Kobiyama K; Lee MSJ; Surucu N; Sag E; Kumanogoh A; Yamamoto M; Gursel M; Ozen S; Kuroda E; Coban C; Ishii KJ
    Front Immunol; 2024; 15():1353336. PubMed ID: 38533502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of STAT and NFkappaB activation by the antitumor agents 5,6-dimethylxanthenone-4-acetic acid and flavone acetic acid in a murine macrophage cell line.
    Ching LM; Young HA; Eberly K; Yu CR
    Biochem Pharmacol; 1999 Oct; 58(7):1173-81. PubMed ID: 10484075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding-pocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA.
    Gao P; Zillinger T; Wang W; Ascano M; Dai P; Hartmann G; Tuschl T; Deng L; Barchet W; Patel DJ
    Cell Rep; 2014 Sep; 8(6):1668-1676. PubMed ID: 25199835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.
    Downey CM; Aghaei M; Schwendener RA; Jirik FR
    PLoS One; 2014; 9(6):e99988. PubMed ID: 24940883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoid extracted from Epimedium attenuate cGAS-STING-mediated diseases by targeting the formation of functional STING signalosome.
    Wang Y; Xu G; Wen J; Zhao X; Zhao H; Lv G; Xu Y; Xiu Y; Li J; Chen S; Yao Q; Chen Y; Ma L; Xiao X; Cao J; Bai Z
    Immunology; 2024 Jun; 172(2):295-312. PubMed ID: 38453210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro on human mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor.
    Philpott M; Ching LM; Baguley BC
    Eur J Cancer; 2001 Oct; 37(15):1930-7. PubMed ID: 11576850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase.
    Zhang SH; Zhang Y; Shen J; Zhang S; Chen L; Gu J; Mruk JS; Cheng G; Zhu L; Kunapuli SP; Ding Z
    J Thromb Haemost; 2013 Oct; 11(10):1855-66. PubMed ID: 23902231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors.
    Guerin MV; Regnier F; Feuillet V; Vimeux L; Weiss JM; Bismuth G; Altan-Bonnet G; Guilbert T; Thoreau M; Finisguerra V; Donnadieu E; Trautmann A; Bercovici N
    Nat Commun; 2019 Sep; 10(1):4131. PubMed ID: 31511510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Structural Differences between Human and Mouse STING Lead to Differing Sensitivity to DMXAA.
    Shih AY; Damm-Ganamet KL; Mirzadegan T
    Biophys J; 2018 Jan; 114(1):32-39. PubMed ID: 29320694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer flavonoids are mouse-selective STING agonists.
    Kim S; Li L; Maliga Z; Yin Q; Wu H; Mitchison TJ
    ACS Chem Biol; 2013 Jul; 8(7):1396-401. PubMed ID: 23683494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Strategy for Investigating the Interactions between STING and Small-Molecule Ligands.
    Xu Y; Li W; Zhou X; Gao Y; Ding L; Xu L; Mao X; Zhou A; Wang X; Ning X
    Langmuir; 2022 Nov; 38(46):14185-14191. PubMed ID: 36354159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview on Vadimezan (DMXAA): The vascular disrupting agent.
    Daei Farshchi Adli A; Jahanban-Esfahlan R; Seidi K; Samandari-Rad S; Zarghami N
    Chem Biol Drug Des; 2018 May; 91(5):996-1006. PubMed ID: 29288534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
    Frémond ML; Uggenti C; Van Eyck L; Melki I; Bondet V; Kitabayashi N; Hertel C; Hayday A; Neven B; Rose Y; Duffy D; Crow YJ; Rodero MP
    Arthritis Rheumatol; 2017 Jul; 69(7):1495-1501. PubMed ID: 28426911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation.
    Sun J; Wang LC; Fridlender ZG; Kapoor V; Cheng G; Ching LM; Albelda SM
    Biochem Pharmacol; 2011 Nov; 82(9):1175-85. PubMed ID: 21819972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.